Histogen

Histogen is a company listed under the stock ticker HSTO (US).

Acquisition, funding and merger involving Histogen.

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

View the org chart displaying its 9 main executives

Most searched biographies at Histogen

• Susan Windham-Bannister, Director
• Jonathan Jackson, Director
• Rochelle Fuhrmann, Director

Popular executive movements at Histogen

• Steven Mento, Executive Chairman and Interim President and Chief Executive Officer, will leave the company on Sep. 30, 2023  (posted on September 22 2023).
• Susan Knudson who is Executive Vice President, Chief Operating Officer and Chief Financial Officer, will be promoted to Chief Executive Officer, Chief Financial Officer, Secretary and Principal Financial Officer on Oct. 1, 2023  (posted on September 22 2023).

Create your alert
to follow the executive moves at Histogen.

Histogen has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Histogen

• Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update | Histogen, Inc.
• Histogen Announces Closing of $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules | Histogen, Inc.
• Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules | Histogen, Inc.
• Histogen Announces 1-for-20 Reverse Stock Split | Histogen, Inc.
• Histogen to Present at the H.C. Wainwright Global Investment Conference | Histogen, Inc.
• Histogen Reports First Quarter 2022 Financial Results and Provides Business Update | Histogen, Inc.
• Histogen to Report First Quarter 2022 Financial Results and Provide Business Update | Histogen, Inc.
• Histogen Announces Closing of $4.75 Million Private Placement | Histogen, Inc.
• Histogen Announces $4.75 Million Private Placement | Histogen, Inc.
• Histogen Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update | Histogen, Inc.
• View more press releases Close

Social media about Histogen

• Histogen on Wikipedia, Google News & Yahoo Finance
• Histogen on LinkedIn, Twitter & YouTube

Contact by email its executives including Rochelle Fuhrmann

Call Histogen at +1 858...

View the org chart

Register to receive your alert

Report an error